CAS: 20928-02-3; 2-Methyldibenzo[b,D]Thiophene

上下游产品

CAS号16452-09-8 Benzenamine,2-[... | CAS号144463-74-1 allyl 2-(4-meth... | CAS号22439-61-8 2-溴二苯并噻吩 | CAS号77-78-1 硫酸二甲酯 | CAS号29289-13-2 2-碘-4-甲基苯胺 | CAS号86-73-7 芴 | CAS号92-52-4 联苯 | CAS号644-08-6 4-甲基联苯 | CAS号643-93-6 3-甲基联苯 | CAS号31317-17-6 2,3-二甲基二苯并噻吩

专利信息

专利号:US-9929363-B2
优先权日:2013-08-05
标题:Composition and synthesis of aggregation-induced emission materials
发明人：TANG BENZHONG; Xie ni; LAM WING YIP
权利人:UNIV HONG KONG SCI & TECH
摘要:The present subject matter relates to compositions containing and synthesis of fluorescent materials e made from tetraphenylethylene (TPE) derivative compounds exhibiting aggregation induced emission (AIE) properties. Further contemplated herein are applications for TPE derivative compounds such as electroluminescent devices since they have a high efficiency, low turn on voltage, and excellent brightness. Additionally, application of TPE derivatives exhibiting AIE properties in various fields such as OLEDs, fingerprinting and forensic technology, and various other biological and industrial sectors are discussed.

专利号:US-2016211470-A1
优先权日:2013-08-05
标 题:Composition and synthesis of aggregation-induced emission materials

专利号:US-2009137566-A1
优先权日:2005-05-26
标 题 :Substituted Piperdines as Renin Inhibitors
发明人：EHARA TAKERU; HITOMI YUKO; KONISHI KAZUHIDE; MASUYA KELICHI
权利人:EHARA TAKERU; HITOMI YUKO; KONISHI KAZUHIDE; MASUYA KELICHI
摘要:The invention relates to substituted 3,4- or higher substituted piperididine compounds, the use thereof for the preparation of a pharmaceutical formulation for the treatment of a disease that depends on activity of renin; the use of a compound of that class in the treatment of a disease that depends on activity of renin; these compounds for use in the diagnostic and therapeutic treatment of a warm-blooded animal, especially for the treatment of a disease (=disorder) that depends on activity of renin; pharmaceutical formulations or products comprising said compounds, and/or a method of treatment comprising administering said compounds, a method for the manufacture of said compounds, as well as novel intermediates, starting materials and/or partial steps for their synthesis. The compounds preferably have the formula I, n n n n n n n n n n wherein the moieties R1, R2, R11 and W are as defined in the specification.